Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas

Journal of Endocrinological Investigation

Volumn 30, Issue 1, 2007, Pages 28-34

  Lee, S J ^a   Choi, K C ^a   Han, J P ^a   Park, Y E ^a   Choi, M G ^a  

^a Hallym University   (South Korea)

Author keywords

Metastasis; Sodium Iodide symporter; Thyroid; Thyroid cancer; Whole body scan

Indexed keywords

IODINE 131; SODIUM IODIDE SYMPORTER; THYROGLOBULIN;

ADULT; AGE; AGE DISTRIBUTION; ARTICLE; CALCULATION; CANCER STAGING; CANCER TISSUE; CARCINOMA CELL; CELL MEMBRANE; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PREDICTION; PROTEIN EXPRESSION; RATING SCALE; SENSITIVITY AND SPECIFICITY; STAINING; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME; WHOLE BODY SCINTISCANNING;

EID: 33947529714     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347392     Document Type: Article

References (35)

1. Carrasco N. Iodide transport in the thyroid gland. Biochem Biophys Acta 1993, 1154:65-82.
2. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996, 379:458-60.
3. Smanik PA, Liu O, Furminger TL, et al. Cloning of the human sodium symporter. Biochem Biophys Res Commun 1996, 226: 339-45.
4. +/ I: Mechanism, stoichiometry, and specificity. J Biol Chem 1997, 272: 27230-8.
5. Schmutzler C, Kohrle J. Implication of the molecurar characterization of the sodium-iodide symporter (NIS). Exp Clin Endocrinol Diabetes 1998, 106:S1-S10.
6. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999, 141: 443-57.
7. Arturi F, Russo D, Giuffrida D, Schlumberger M, Filetti S. Sodium-iodide symporter (NIS) gene expression in lymphnode metastases of papillary thyroid carcinomas. Eur J Endocrinol 2000, 143:623-7.
8. McDougall IR. In vivo radionuclide tests and imaging. In: Braverman LE, Utiger RD eds. The Thyroid. 9th ed. Philadelphia: Lippincott Williams and Wilkins. 2005, 309-28.
9. Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Matab 1997, 82: 1638-41.
10. + /I-symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 1999, 84: 3228-34.
11. +/I-symporter distribution in human thyroid tissues: an immunohistochemical study. J Clin Endocrinol Metab 1998, 83: 4102-6.
12. Ryu KY, Senokozlieff ME, Smanik PA, et al. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter. Thyroid 1999, 9: 405-9.
13. Spitzweg C, Heufelder AE, Morris UC. Thyroid iodine transport. Thyroid 2000, 4: 321-30.
14. Russo D, Manole D, Arturi F, et al. Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas. Thyroid 2001, 11: 37-9.
15. Saito T, Endo T, Kawaguchi A, et al. Increased expression of the sodium/ iodide symporter in papillary thyroid carcinomas. J Clin Invest 1998, 101: 1296-300.
16. +/I symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 2001, 86: 2697-700.
17. Park HJ, Kim JY, Park KY, Gong C, Hong SJ, Ahn IM. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid 2000, 10: 211-7.
18. Arturi F, Russo D, Bidart JM, Scarpelli D, Schlumberger M, Filetti S. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. Eur J Endocrinol 2001, 145: 129-35.
19. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer correlation with radioiodine uptake. J Clin Endocrinol Metab 2001, 86: 5627-32.
20. Min J-J, Chung J-K, Lee YJ, et al. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 2001, 28: 639-45.
21. Arturi F, Russo D, Schlumberger M, et al. Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 1998, 83: 2493-6.
22. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989, 63: 908-11.
23. American Joint Committee on Cancer. Cancer staging manual. New York: Springer-Verlag. 2002, 77-87.
24. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993, 114: 1050-8.
25. Gerard AC, Daumerie C, Mestdagh C, et al. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol Metab 2003, 88: 4977-83.
26. Kim HM, Lee HC, Park KS, et al. A study on the urinary iodide excretion in normal subjects and patients with thyroid disease. Korean J Intern Med 1985, 29: 625-31.
27. Tonacchera M, Viacava P, Agretti P, et al. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J Clin Endocrinol Metab 2002, 87: 352-7.
28. Wapnir IE, van de Rijn M, Nowels K, et al. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 2003, 88: 1880-8.
29. Trapasso F, Iuliano R, Chiefari E, et al. Iodide symporter gene expression in normal and transformed rat thyroid cells. Eur J Endocrinol 1999, 140: 447-51.
30. Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM. Expression, exon-intron organization, and chromosome mapping of human sodium iodide symporter. Endocrinology 1997, 138: 3555-8.
31. Riedel C, Levy O, Carrasco N. Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 2001, 276: 21458-63.
32. + /I-symport activity is present in membrane vesicles from thyrotropin-derived non-I-transporting cultured thyroid cells. Proc Natl Acad Sci USA 1994, 91: 3789-93.
33. +/ I symporter gene methylation status. J Clin Endocrinol Metab 1999, 84: 2449-57.
34. Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, et al. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. Am J Pathol 2004, 165:25-34.
35. Schlumberger M, Challeton C, de Vathaire F, et al. Radioactive iodide treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996, 37: 598-605.